WisdomTree China ex-State-Owned Enterprises Fund (CXSE)
Live price chart, market sentiment, and community perspectives for WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ: CXSE).
Live price chart, market sentiment, and community perspectives for WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ: CXSE).
On our desk, we are viewing CXSE as a cleaner vehicle for Chinese exposure because it systematically filters out state-owned enterprises where government ownership exceeds 20%. By stripping away the slow-growth banking and energy monopolies, the fund captures the entrepreneurial economy. However, with Alibaba and Tencent anchoring roughly 17% of total assets, we have to remind clients that concentration risk is high. If Beijing initiates another round of regulatory crackdowns, this private-sector tilt will take the brunt of the volatility.
When evaluating CXSE for growth-oriented portfolios, our research highlights its outperformance during the 2025 market rebound when the MSCI China Index jumped significantly. The structural thesis relies on China's rising private sector market share, currently hovering around 40%. Because state-controlled entities tend to occupy slow-moving value and defensive sectors, CXSE's deliberate pivot toward IT, communications, and healthcare provides the high-beta profile we want during broader emerging market rallies.
Looking at the quantitative profile, CXSE carries a net expense ratio of 0.32% and a moderate asset base around $503 to $504 million. Liquidity is moderate, meaning execution desks should always advise retail and institutional clients to utilize limit orders rather than market orders to avoid slippage. The trailing P/E sits at 16.6x with an 8.6% long-term EPS growth rate, making it look fairly valued relative to historical emerging market discounts, but short-term alpha has flattened out recently.
From a macroeconomic perspective, sentiment remains divided. While some analysts flag CXSE as a potential 2026 star built on ongoing Beijing stimulus and export diversification, others note that it has struggled with negative alpha over the past year. Morningstar rates the fund with a Medalist rating and a Large Blend equity style box, but investors need to balance the long-term structural tailwinds of China's private enterprises against current uneven macroeconomic GDP growth projections.
Our risk management team emphasizes that while CXSE successfully neutralizes direct state influence by excluding companies with greater than 20% government ownership, it remains deeply tied to broader Chinese consumer sentiment and tech sector dynamics. The 30-day SEC yield sits around 1.06% to 1.15%, and the distribution yield is near 0.95%. Income is clearly a secondary consideration here; this product is bought exclusively for capital appreciation driven by new economy sectors.
Explore plasma cleansing, somatic organ swaps, and BCI.